TherapeuticsMD Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,775.60
15,026.20
20,142.90
19,356.50
16,777.70
16,099.50
Cost of Goods Sold (COGS) incl. D&A
2,017.70
3,724.30
4,569.10
4,318.20
2,850.10
3,031.50
Gross Income
6,757.90
11,301.90
15,573.80
15,038.30
13,927.70
13,067.90
SG&A Expense
32,816.10
65,343.00
100,764.00
105,291.90
91,556.40
143,288.10
EBIT
26,058.20
54,041.10
85,190.20
90,253.60
77,628.70
130,220.20
Unusual Expense
250.00
-
-
-
-
-
Non Operating Income/Expense
34.50
213.50
95.70
367.30
695.60
2,280.80
Interest Expense
2,672.80
-
-
-
-
4,677.80
Pretax Income
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
Consolidated Net Income
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
Net Income
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
Net Income After Extraordinaries
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
Net Income Available to Common
28,419.30
54,217.20
85,077.00
89,875.50
76,925.40
132,617.20
EPS (Basic)
0.22
0.36
0.49
0.46
0.37
0.59
Basic Shares Outstanding
127,569.70
149,727.20
173,174.20
196,088.20
205,523.30
225,026.30
EPS (Diluted)
0.22
0.36
0.49
0.46
0.37
0.59
Diluted Shares Outstanding
127,569.70
149,727.20
173,174.20
196,088.20
205,523.30
225,026.30
EBITDA
26,000.10
53,988.60
85,127.80
90,121.20
77,415.60
129,926.30
Non-Operating Interest Income
27.20
37.30
17.40
10.80
7.70
-
About TherapeuticsMD
View Profile
